Enterprise Value
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary
- AGLE enterprise value is not available.
Performance
AGLE Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
AGLE Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| 6 m6 months | - | - | - |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
AGLE Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | ||||
| 1 y | 1-year | ||||
| 3 y | 3-year | $207 M | -$196 M | ||
| 5 y | 5-year | $485 M | -$196 M | ||
| alltime | all time | $485 M | -$196 M |
Aeglea BioTherapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2023 | -$3.46 M(+318.6%) |
| 2022 | -$826.50 K(-100.4%) |
| 2021 | $224.35 M(-23.4%) |
| 2020 | $292.80 M(+40.8%) |
| Date | Value |
|---|---|
| 2019 | $208.02 M(+31.4%) |
| 2018 | $158.35 M(+104.7%) |
| 2017 | $77.37 M(+624.9%) |
| 2016 | $10.67 M |
FAQ
- What is the all time high enterprise value for Aeglea BioTherapeutics?
What is the all time high enterprise value for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high enterprise value is $484.62 M